Xue Song

2.9k total citations
101 papers, 2.1k citations indexed

About

Xue Song is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xue Song has authored 101 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Xue Song's work include Cancer-related molecular mechanisms research (11 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and RNA modifications and cancer (9 papers). Xue Song is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and RNA modifications and cancer (9 papers). Xue Song collaborates with scholars based in China, United States and United Kingdom. Xue Song's co-authors include Jonathan Skinner, Jason M. Sutherland, Julie Bynum, Elliott S. Fisher, John E. Wennberg, James M. Whedon, Daniel J. Gottlieb, Kathryn Andrews, Weiping Zhou and Tami L. Mark and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xue Song

93 papers receiving 2.0k citations

Peers

Countries citing papers authored by Xue Song

Since Specialization

Citations

This map shows the geographic impact of Xue Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Song more than expected).

Fields of papers citing papers by Xue Song

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Song. The network helps show where Xue Song may publish in the future.

Co-authorship network of co-authors of Xue Song

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Song. A scholar is included among the top collaborators of Xue Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Song. Xue Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Malignant phyllodes tumors with sarcomatous components: A histopathologic and molecular study 2025 ·Translational Oncology ·Ting Lei, Xue Song, (unknown), (unknown), (unknown), Xu Deng, (unknown), (unknown), Qing Li	0
2	Prediction of Patients With High-Risk Osteosarcoma on the Basis of XGBoost Algorithm Using Transcriptome and Methylation Data From SGH-OS Cohort 2025 ·JCO Precision Oncology ·Weisong Zhao, (unknown), Zhenxiang Dai, Lulu Zhang, Zhiwei Cheng, Xue Song, (unknown), Zhuoying Wang, Kai Tian, Yafei Jiang, Wei Sun, Zhengdong Cai, Gangyang Wang, Yingqi Hua	0
3	Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells 2025 ·Journal of Pharmacy and Pharmacology ·(unknown), Shengli Pang, Yi-Chun Li, Xue Song, Huan Tang, Hong Lv, Fuwen Luo, Yue Pan	0
4	Wenshen Yiqi Granule Alleviates Chronic Obstructive Pulmonary Disease via the Long Noncoding RNA‐XIST/MicroRNA‐200c‐3p Axis 2025 ·Pulmonary Circulation ·(unknown), Shiping Zhu, (unknown), Xue Song, Xiangshu Jin, (unknown)	0
5	Emerging causes of anticancer therapies−induced Stevens-Johnson syndrome and toxic epidermal necrolysis: evidence from disproportionality analysis of the FDA adverse event reporting system 2025 ·Frontiers in Immunology ·Wensheng Liu, Xue Song, Qiong Du, Jiyong Liu	0
6	Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy 2024 ·Frontiers in Oncology ·(unknown), Xue Song, (unknown), Neil Blake, (unknown), Meng Jia	11
7	Molecular and immunological characteristics of postoperative relapse in lymph node‐positive esophageal squamous cell cancer 2024 ·Cancer Medicine ·(unknown), (unknown), Chan Zhu, Si Li, Huan Yi, Xing Zhang, (unknown), Xue Song, Dongsheng Chen, (unknown)	1
8	Intraoperative Radiotherapy as a Tumour-Bed Boost Combined with Whole Breast Irradiation Versus Conventional Radiotherapy in Patients with Early-Stage Breast Cancer: A Systematic Review and Meta-analysis 2023 ·Annals of Surgical Oncology ·(unknown), (unknown), Lingling Ye, Yang Sun, Yan Dai, Xue Song, (unknown), (unknown)	2
9	Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs 2023 ·Journal of the National Comprehensive Cancer Network ·Vivek Narayan, Tao Liu, Xue Song, Joshua D. Mitchell, JoRean D. Sicks, Ilana F. Gareen, Lova Sun, Srinivas Denduluri, Ciarán Fisher, (unknown), (unknown), Joseph Vadakara, Naomi B. Haas, Kenneth B. Margulies, Bonnie Ky	2
10	Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment 2023 ·Frontiers in Oncology ·(unknown), Shaorong Yu, (unknown), Xue Song, (unknown), Ming Jiang, Jun Zhu, Jianhua Xu, Lijun Zhao, Zhen Guo, Jianfeng Wu, (unknown), (unknown)	5
11	LncRNA OXCT1-AS1 promotes the proliferation of non-small cell lung cancer cells by targeting the miR-195/CCNE1 axis 2022 ·Translational Cancer Research ·Dapeng Wang, Ying Chen, Xue Song, Shuang Wu, Na Zhang, Fei Zheng, (unknown)	7
12	1386P Anlotinib combined with whole brain radiation therapy (WBRT) for advanced non-small cell lung cancer with multiple brain metastases: An open-label, single-arm phase II trial 2020 ·Annals of Oncology ·(unknown), Hua Tao, (unknown), Xue Song, Ning Zhang, (unknown), Ning Jiang, Lijun Zhao, (unknown), Xia He	3
13	Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer 2020 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Meiqi Shi, Li Wang, Cheng Chen, Tao Hua, Ning Jiang, Pengwei Yan, Lijun Zhao, Xue Song, Xia He	15
14	An evaluation comparing Californium252 neutron brachytherapy with neoadjuvant intra-arterial embolism chemotherapy assisted surgery effect for treating advanced cervical carcinoma patients. 2015 ·PubMed ·(unknown), (unknown), (unknown), Hongyu Shen, (unknown), Jennifer Tan, Long Liang, Xue Song	2
15	Overall survival in patients with metastatic melanoma 2015 ·Current Medical Research and Opinion ·Xue Song, Zhongyun Zhao, Beth Barber, Amanda M. Farr, (unknown), (unknown)	53
16	Medical Costs by Disease Stage in Medicare Patients with Melanoma 2014 ·Value in Health ·A. Farr, Zhongyun Zhao, Xue Song, Beth Barber, (unknown)	1
17	Geographic and Sociodemographic Disparities in PET Use by Medicare Beneficiaries With Cancer 2012 ·Journal of the American College of Radiology ·Tracy Onega, Tor D. Tosteson, Qianfei Wang, Bruce E. Hillner, Xue Song, Barry A. Siegel, Anna N.A. Tosteson	25
18	Thyroid hormone β receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys 2009 ·British Journal of Pharmacology ·(unknown), (unknown), Edward E. Cable, Xue Song, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	37
19	Costs associated with complications are lower with capecitabine than with 5‐fluorouracil in patients with colorectal cancer 2009 ·Cancer ·Edward Chu, Kathy L. Schulman, (unknown), Xue Song	23
20	A Projection of the Impact of Lipid-Lowering Therapy on High-Risk Employee Disability and Medical Costs 2006 ·Journal of Occupational and Environmental Medicine ·Xue Song, Daniel M. Huse, Setareh A. Williams, Gerald M. Borok, (unknown), Ronald J. Ozminkowski	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact